"Demand for our products and solutions remains very high. The Group grew organically by 1.4%, supported by a strong order intake and an order book for capital equipment which is now significantly higher than at the end of the corresponding period last year. The global challenges within supply chain remain, and the organization continues to manage the situation with sharp focus," says Joacim Lindoff, President & CEO.
"We have a high activity level that is now approaching the level we saw before the pandemic, and we continue to implement our strategy with full force. A brand new generation of mattresses for preventing pressure injuries was launched during the quarter that, together with the SEM scanner, further strengthens our offering within pressure injury prevention. With continued high demand for capital equipment, service and rental I look forward to another successful 2022 for Arjo," concludes Joacim Lindoff.January-March 2022 in brief
Net sales grew organically by 1.4%.
- Net sales increased to SEK 2,370 M (2,168).
- Adjusted EBITDA amounted to SEK 490 M (495).
- Adjusted operating profit amounted to SEK 237 M (260).
- Profit after financial items amounted to SEK 218 M (231).
- Earnings per share amounted to SEK 0.60 (0.64).
- Cash flow from operations amounted to SEK 25 M (275).
- Cash conversion was 5.3% (56.5).
- AtmosAir Velaris was launched during the quarter, a new generation of mattresses for pressure injury prevention.
Fund managers, analysts and the media are invited to a teleconference on April 22 at 08.00 CEST. Please see details below to join the conference:
Sweden: +46 8505583 58
USA: +1 646 722 4957
UK: +44333300 9034
A presentation will be held during the telephone conference. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q1-2022
Alternatively, use the following link to download the presentation:
A recording of the teleconference will be available for 90 days via the following link: https://tv.streamfabriken.com/arjo-q1-2022
For more information, please contact:
Maria Nilsson, Acting EVP Marketing Communication & Public Relations
Tel: +46 734 244 515
Sara Ehinger, VP Investor Relations & Corporate Communications
Tel: +46 723 597 794
This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on April 22, 2022.
At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With 6,500 people worldwide and 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com